A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy drug delays cancer recurring or worsening in global trial )
Also on site :
- Moderna's new COVID-19 vaccine mNexspike approved by FDA
- Sydney Sweeney finally confirms she’s single after split from fiancé and Glen Powell dating rumors
- Seven dead after bridges collapse in two Russian regions near Ukraine